Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
Lindsay Robertson(University of York), Lauren E. Jones(Newcastle upon Tyne Hospitals NHS Foundation Trust)
Cited by 126
Related Papers
Defining and conceptualising the commercial determinants of health
|The Lancet|2023|644